Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
1999 4
2000 2
2001 1
2002 4
2003 4
2004 4
2005 4
2006 3
2007 2
2008 3
2009 8
2010 8
2011 4
2012 3
2013 2
2015 3
2016 6
2017 5
2018 2
2019 7
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Results by year
Filters applied: . Clear all
Page 1
Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.
Janovec V, Hodek J, Clarova K, Hofman T, Dostalik P, Fronek J, Chlupac J, Chaperot L, Durand S, Baumert TF, Pichova I, Lubyova B, Hirsch I, Weber J. Janovec V, et al. Among authors: chaperot l. Sci Rep. 2020 Jul 29;10(1):12767. doi: 10.1038/s41598-020-69614-7. Sci Rep. 2020. PMID: 32728070 Free PMC article.
Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.
Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, Kaplan MJ. Villanueva E, et al. Among authors: chaperot l. J Immunol. 2011 Jul 1;187(1):538-52. doi: 10.4049/jimmunol.1100450. Epub 2011 May 25. J Immunol. 2011. PMID: 21613614 Free PMC article.
T-cell receptor diversity as a prognostic biomarker in melanoma patients.
Charles J, Mouret S, Challende I, Leccia MT, De Fraipont F, Perez S, Plantier N, Plumas J, Manuel M, Chaperot L, Aspord C. Charles J, et al. Among authors: chaperot l. Pigment Cell Melanoma Res. 2020 Jul;33(4):612-624. doi: 10.1111/pcmr.12866. Epub 2020 Feb 3. Pigment Cell Melanoma Res. 2020. PMID: 31971658
Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display.
Vragniau C, Bufton JC, Garzoni F, Stermann E, Rabi F, Terrat C, Guidetti M, Josserand V, Williams M, Woods CJ, Viedma G, Bates P, Verrier B, Chaperot L, Schaffitzel C, Berger I, Fender P. Vragniau C, et al. Among authors: chaperot l. Sci Adv. 2019 Sep 25;5(9):eaaw2853. doi: 10.1126/sciadv.aaw2853. eCollection 2019 Sep. Sci Adv. 2019. PMID: 31620562 Free PMC article.
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
Ouaguia L, Dufeu-Duchesne T, Leroy V, Decaens T, Reiser JB, Sosa Cuevas E, Durantel D, Valladeau-Guilemond J, Bendriss-Vermare N, Chaperot L, Aspord C. Ouaguia L, et al. Among authors: chaperot l. Clin Transl Immunology. 2020 Dec 8;9(12):e1208. doi: 10.1002/cti2.1208. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33312564 Free PMC article.
BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients.
Sosa Cuevas E, Ouaguia L, Mouret S, Charles J, De Fraipont F, Manches O, Valladeau-Guilemond J, Bendriss-Vermare N, Chaperot L, Aspord C. Sosa Cuevas E, et al. Among authors: chaperot l. Clin Transl Immunology. 2020 Nov 24;9(11):e1190. doi: 10.1002/cti2.1190. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33282290 Free PMC article.
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.
Charles J, Chaperot L, Hannani D, Bruder Costa J, Templier I, Trabelsi S, Gil H, Moisan A, Persoons V, Hegelhofer H, Schir E, Quesada JL, Mendoza C, Aspord C, Manches O, Coulie PG, Khammari A, Dreno B, Leccia MT, Plumas J. Charles J, et al. Among authors: chaperot l. Oncoimmunology. 2020 Apr 12;9(1):1738812. doi: 10.1080/2162402X.2020.1738812. eCollection 2020. Oncoimmunology. 2020. PMID: 32313721 Free PMC article.
83 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page